Literature DB >> 9681691

Immunohistochemical localization of the murine transferrin receptor (TfR) on blood-tissue barriers using a novel anti-TfR monoclonal antibody.

K Kissel1, S Hamm, M Schulz, A Vecchi, C Garlanda, B Engelhardt.   

Abstract

A novel monoclonal antibody (mAb), 8D3 (IgG2a), that specifically recognizes the murine transferrin receptor (TfR) was produced by immunizing a Lewis rat with a polyoma middle T oncogene-transformed endothelioma cell line. The 8D3 mAb was obtained by immunohistochemical screening for exclusive staining of vessels forming a blood-brain barrier (BBB), but not of other vessels. The anti-TfR mAb 8D3 recognizes the TfR also in FACS analysis and in western blots and should prove to be useful for affinity purification of the TfR. Whereas 8D3 brightly stains BBB-forming vessels in the central nervous system of mice, it does not stain the fenestrated capillaries within the choroid plexus and the circumventricular organs. In testis, where the blood-tissue barrier is located at the level of the Sertoli cells, the 8D3 mAb specifically stains Sertoli cells but not endothelial cells. Finally, in vitro, 8D3 does not interfere with iron uptake of lymphocytes as it does not influence their proliferation. Taken together, 8D3 represents a versatile new tool to study the tissue distribution of the murine TfR and TfR-mediated transcytosis across tissue barriers in the mouse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9681691     DOI: 10.1007/s004180050266

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  30 in total

Review 1.  Toxicology of choroid plexus: special reference to metal-induced neurotoxicities.

Authors:  W Zheng
Journal:  Microsc Res Tech       Date:  2001-01-01       Impact factor: 2.769

2.  Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood-brain barrier-associated cell types.

Authors:  J A Lockman; W J Geldenhuys; K A Bohn; S F Desilva; D D Allen; C J Van der Schyf
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

3.  Ferroportin-mediated iron export from vascular endothelial cells in retina and brain.

Authors:  Bailey H Baumann; Wanting Shu; Ying Song; Elizabeth M Simpson; Samira Lakhal-Littleton; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2019-07-16       Impact factor: 3.467

4.  VIPER is a genetically encoded peptide tag for fluorescence and electron microscopy.

Authors:  Julia K Doh; Jonathan D White; Hannah K Zane; Young Hwan Chang; Claudia S López; Caroline A Enns; Kimberly E Beatty
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-05       Impact factor: 11.205

5.  Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.

Authors:  Jijin Gu; Karam Al-Bayati; Emmanuel A Ho
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

Review 6.  Developing therapeutic antibodies for neurodegenerative disease.

Authors:  Y Joy Yu; Ryan J Watts
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

7.  Brain-specific expression of an exogenous gene after i.v. administration.

Authors:  N Shi; Y Zhang; C Zhu; R J Boado; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

8.  Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures.

Authors:  Julie A Gaasch; Werner J Geldenhuys; Paul R Lockman; David D Allen; Cornelis J Van der Schyf
Journal:  Neurochem Res       Date:  2007-04-03       Impact factor: 3.996

Review 9.  Brain barrier systems: a new frontier in metal neurotoxicological research.

Authors:  Wei Zheng; Michael Aschner; Jean-Francois Ghersi-Egea
Journal:  Toxicol Appl Pharmacol       Date:  2003-10-01       Impact factor: 4.219

10.  Comparative binding, endocytosis, and biodistribution of antibodies and antibody-coated carriers for targeted delivery of lysosomal enzymes to ICAM-1 versus transferrin receptor.

Authors:  Jason Papademetriou; Carmen Garnacho; Daniel Serrano; Tridib Bhowmick; Edward H Schuchman; Silvia Muro
Journal:  J Inherit Metab Dis       Date:  2012-09-12       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.